New AI research tool can predict plasma cell cancer outcomes instantly by reading standard biopsy slides, boosting precision ...

C. Ola Landgren, M.D., Ph.D., received HealthTree Foundation's prestigious 2025 Innovation Award for his work in developing CORAL, a new research tool that leverages AI to predict individual outcomes ...

After a blood cancer diagnosis, one Arkansas endurance cyclist is back on his bike — just 13 months after treatment, he's ...

A private hospital in Bengaluru successfully performs day-care bone marrow transplants, reducing costs and treatment duration for select blood cancer patients.

Hematologists and oncologists from UC San Francisco shared research results and clinical guidance at the world’s premier meeting for malignant and non-malignant hematology at the American Society of ...

Soefje also discusses the growing role of pharmacists, technology, and comparative efficacy data in improving adherence, ...

In this interview Ira Zackon, MD, highlights data on bispecific antibody use in patients with multiple myeloma in the community setting as presented at ASH 2025.

Patients share their unexpected journeys with multiple myeloma, revealing challenges and resilience in the face of a cancer ...

Teclistamab (Tecvayli) is an off-the-shelf first-in-class bispecific monoclonal antibody shown in the MajesTEC-1 trial to ...

Patients share their emotional journeys and coping strategies after cancer diagnoses, highlighting the importance of support ...

Experts discuss the evolving role of bispecific antibodies in multiple myeloma, highlighting treatment advancements and ...

Vyriad Inc., a Rochester-based biotech business that develops specialty viruses to fight cancers, said this week it's closed ...